Rubella in Poland in 2013
Journal Title: Przegląd Epidemiologiczny - Year 2015, Vol 69, Issue 2
Abstract
BACKGROUND. In 2004, Poland has adopted the WHO goal of rubella elimination and congenital rubella syndrome prevention. The main target of the Programme is to stop transmission of the virus in the environment and prevention of congenital rubella in children. This can be achieved by carrying out the vaccination. Participation in the rubella elimination program requires clinical diagnosis of rubella cases and their confirmation with laboratory test. In Poland, until 2003, national vaccination recommendation included a dose of rubella vaccine only for girls aged 13 years. Among men, the incidence of measles remained high creating a risk of infection of non-immune pregnant women which may lead to the development of congenital rubella syndrome in the child. AIM. To assess epidemiological situation of rubella in Poland in 2013, including vaccination coverage in Polish population. METHODS. The descriptive analysis was based on data retrieved from routine mandatory surveillance system and published in the annual bulletins “Infectious diseases and poisonings in Poland in 2013” and “Vaccinations in Poland in 2013” (MP. Czarkowski, Warszawa 2014, NIZP-PZH, GIS). RESULTS. In 2013, there was big epidemic of rubella in Poland – with 38 548 registered cases (6 times more than in 2012), incidence 84.4 per 100 000 (5 times higher than in the previous year). The highest incidence rate, regardless of gender and the environment, was observed among adolescents aged 15-19 years (911.6 per 100,000). The incidence of rubella in boys and men was significantly higher than the incidence in girls and women (181.4 versus 23.9). In 2013, two cases of congenital rubella syndrome were registered. SUMMARY AND CONCLUSIONS. Rubella epidemic which occurred in Poland in 2013 was the result of use in the past vaccination against rubella only for girls 13 years of age. The proportion of laboratory tests confirming/ excluding rubella infection is still very low in Poland. In 2013, only 0.2% of rubella cases were laboratory confirmed.
Authors and Affiliations
Monika R. Korczyńska, Iwona Paradowska-Stankiewicz
Keywords
Related Articles
- EP ID EP71871
- DOI -
- Views 85
- Downloads 0
Men treated for syphilis in Białystok, Poland,2014-2018 / Mężczyźni leczeni z powodu kiły w Białymstoku w latach 2014-2018
INTRODUCTION. Incidence of syphilis is increasing in Europe in recent years, mainly due to high incidence in men, especially men who have sex with men (MSM). AIM. To analyse sociodemographic, epidemiological and clinica...
Mumps in Poland in 2016 / Świnka w Polsce w 2016 roku
BACKGROUND: Vaccination against mumps from 2003 is mandatory in Poland and given as two dose scheme with MMR vaccine (mumps, measles, and rubella). Earlier this vaccination was only recommended. Despite observed decline...
Repellents as a major element in the context of prevention of tick-borne diseases / Repelenty jako kluczowy element profilaktyki w kontekście zapobiegania chorobom odkleszczowym
In Poland, out of the 21 species of ticks described, two species have the greatest epidemiological significance: Ixodes ricinus and Dermacentor reticulatus. Their participation in the transmission of etiologic agents of...
Key role of public health in improving health situation of the population / Kluczowa rola zdrowia publicznego w poprawie sytuacji zdrowotnej ludności
No country (and no national budget) in which there is no efficient public health system (disease prevention and health promotion) is able to cover the exponentially growing costs of medical care for the aging population...
Babeszjoza u ludzi
Babesia to pasożytnicze pierwotniaki krwinek czerwonych przenoszone przez kleszcze. Zachorowania u ludzi wywołuje kilka spośród ponad stu dotychczas opisanych gatunków/genotypów Babesia, najczęściej są to: B. microti, B....